STAT3 pS727 Antibody, anti-human, REAfinity™
Synonyms: ADMIO, APRF, HIES
RECOMBINANT EXTENDED VALIDATION
Bioz Star90/100 Bioz rating
1 Citation1 Image
Clone:
REA324 | 49/p-Stat3
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for STAT3 pS727 Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
PE
Vio B515
Vio R667
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-124-250, 130-124-297
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 50 ng/mL recombinant human IL-6 for 15 minutes at 37 °C, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with Anti-STAT3 pS727 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. CD33+ cells were pre-gated for the analysis. Cell debris were excluded from the analysis based on scatter signals.

Application image
Intracellular flow cytometry applications
APC
Vio R667
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 50 ng/mL recombinant human IL-6 for 15 minutes at 37 °C, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were stained with Anti-STAT3 pS727 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. CD33+ cells were pre-gated for the analysis. Cell debris were excluded from the analysis based on scatter signals.
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
frozen – PFA
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-124-250, 130-124-297
Testing grade:
Extended validation for STAT3 pS727 Antibody, anti-human, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA324
49/p-Stat3
high

Cells were incubated with an excess of purified unconjugated STAT3 pS727 (REA324) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for STAT3 pS727 Antibody, anti-human, REAfinity™
Overview

Clone REA324 recognizes the signal transducer and activator of transcription 3 (STAT3) antigen phosphorylated at serine 727 (pS727). STAT3 expression is found ubiquitously. It is activated in response to various growth factors, hormones, and cytokines, and has an important role in their signaling. When these ligands bind to the specific transmembrane STAT3 receptor, STAT3 becomes activated by tyrosine phosphorylation of two important phosphorylation sites, pY705 and pS727. The dimeric STAT3 translocates to the nucleus, where it binds to consensus STAT3 binding sequences within the promoter region of target genes and thereby activates their transcription. The persistent activation of STAT3 also mediates tumor-promoting inflammation. STAT3 promotes pro-oncogenic inflammatory pathways in tumor inflammation and immunity, including nuclear factor-κB and interleukin-6-GP130-Janus kinase pathways, and by opposing STAT1- and NF-κB-mediated T helper 1 anti-tumor immune responses.

Additional information: Clone REA324 displays negligible binding to Fc receptors.

Alternative names

ADMIO, APRF, HIES

Detailed product information

Technical specifications

Clone
REA324
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
STAT3 pS727
Molecular mass of antigen [kDa]
88
Distribution of antigen
other
Entrez Gene ID
RRID
AB_2928853, AB_2653579, AB_2928854, AB_2653578, AB_2905400, AB_2905401, AB_2811548, AB_2811579

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for STAT3 pS727 Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?